News
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
A South Korean biotech’s GLP-1 candidate has reduced liver fat in patients with metabolic dysfunction-associated ...
A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat. Antioxidants and other compounds in coffee (even decaf) can help protect against ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
More American teenagers now use the weight-loss drug Wegovy, as doctors and families grow more comfortable with the treatment ...
Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.
The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results